BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3118394)

  • 21. N-ethylmaleimide inhibits Ca2+ influx induced by collagen or arachidonate on rabbit platelets.
    Sato T; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 May; 928(3):266-71. PubMed ID: 3105597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function.
    Ouyang C; Huang TF
    Toxicon; 1984; 22(5):705-18. PubMed ID: 6441310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of anti-platelet aggregating action of dilazep.
    Takenaga M; Kitagawa H; Hirai A; Tamura Y; Yoshida S
    J Pharmacobiodyn; 1985 Feb; 8(2):77-83. PubMed ID: 3925115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis.
    Raghavendra RH; Naidu KA
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):73-8. PubMed ID: 19501497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human platelet function in vitro and ex vivo by acetaminophen.
    Lages B; Weiss HJ
    Thromb Res; 1989 Mar; 53(6):603-13. PubMed ID: 2499947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of rabbit platelet activation by lipoxygenase products of arachidonic and linoleic acid.
    Coene MC; Bult H; Claeys M; Laekeman GM; Herman AG
    Thromb Res; 1986 Apr; 42(2):205-14. PubMed ID: 3087009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Feb; 21(2):177-85. PubMed ID: 3083435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
    Lagarde M; Guichardant M; Ghazi I; Dechavanne M
    Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acrolein on human platelet aggregation.
    Selley ML; Bartlett MR; McGuiness JA; Ardlie NG
    Chem Biol Interact; 1990; 76(1):101-9. PubMed ID: 2118426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.